Specialist-based treatment reduces the severity of allergic rhinitis

Clinical and Experimental Allergy

Volumn 43, Issue 7, 2013, Pages 723-729

  Mullol, J ^a,b,e   Bartra, J ^a,b,e   Del Cuvillo, A ^c   Izquierdo, I ^d   Munoz Cano R ^a,b,e   Valero, A ^a,b,e  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL DE JEREZ   (Spain)

^d Grupo Uriach   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Allergic rhinitis; Modified ARIA classification; Quality of life; Severity

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CLINICAL PRACTICE; CONJUNCTIVITIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SPAIN; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; ASTHMA; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; SEVERITY OF ILLNESS INDEX;

EID: 84879539261     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12081     Document Type: Article

References (15)

1. Bousquet J, Khaltaev A, Cruz A et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008; 63 (Suppl 86):8-160.
2. Bousquet J, Lund VJ, van Cauwenberge P et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 2003; 58:733-41.
3. Van Hoecke H, Vastesaeger N, Dewulf L, De Bacquer D, van Cauwenberge P. Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice? J Allergy Clin Immunol 2006; 118:758-9.
4. Demoly P, Urbinelli R, Allaert FA, Bousquet PJ. Should we modify the allergic rhinitis and its impact on asthma dichotomic classification of severity? Allergy 2010; 65:1488-90.
5. Bousquet PJ, Combescure C, Neukirch F et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007; 62:367-72.
6. Valero A, Ferrer M, Sastre J et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic rhinitis and its impact on asthma severity items. J Allergy Clin Immunol 2007; 120:359-65.
7. Valero A, Ferrer M, Baró E et al. Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis. Allergy 2010; 65:1609-13.
8. Spector SL, Nicklas RA, Chapman JA et al. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; Joint Council of Allergy, Asthma, and Immunology. Symptom severity assessment of allergic rhinitis: part 1. Ann Allergy Asthma Immunol 2003; 91:105-114.
9. ESPRINT Study Group and Investigators. Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: the ESPRINT questionnaire. Value Health 2007; 10:466-77.
10. Valero A, Alonso J, Antépara I et al. Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnaires. Allergy 2007; 62:1372-78.
11. Valero A, Baró E, Sastre J et al. Reference values for facilitating the interpretation of the ESPRINT-15 Questionnaire (Spanish version). J Investig Allergol Clin Immunol 2009; 19:396-403.
12. Del Cuvillo A, Montoro J, Bartra J et al. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort study. Rhinology 2010; 48:201-5.
13. Castillo JA, Molina J, Valero A, Mullol J. Prevalence and characteristics of rhinitis in asthmatic patients attended in primary care in spain (RINOASMAIR Study). Rhinology 2010; 48:35-40.
14. Bousquet J, Bachert C, Canonica GW et al. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol 2009; 124:428-33.
15. Bousquet P-J, Bachert C, Canonica GW et al. Uncontrolled allergic rhinitis during treatment and its impact on quality-of-life. A cluster randomized trial. J Allergy Clin Immunol 2010; 126:666-8.